The 5th Canadian Symposium on Hepatitis C Virus: We Are Not Done Yet-Remaining Challenges in Hepatitis C.
A summary of the 5th Canadian Symposium on Hepatitis C Virus: “We’re not done yet: remaining challenges in Hepatitis C”
View PublicationA summary of the 5th Canadian Symposium on Hepatitis C Virus: “We’re not done yet: remaining challenges in Hepatitis C”
View PublicationIdentifying socio-demographic and clinical correlates of viral suppression and rebound
View PublicationA review highlighting the role played by the kynurenine pathway, which establishes and maintains immune-privileged sites while contributing to cancer immune escape
View PublicationInvestigating the effect of iterative reconstruction on coronary plaque volume and composition
View PublicationEvaluating the immunogenicity and safety of the quadrivalent HPV (qHPV) vaccine in HIV-positive women over 24 months
View PublicationSystematic review of the association between food insecurity and achieving complete HIV viral suppression
View PublicationReviewing current trends in mortality and the potential for early cART and HCV therapy to improve survival in coinfected patients
View PublicationExploring how metabolic activity may interfere with the host molecular signaling involved in the survival of memory CD4 T cells
View PublicationPresenting CHIWOS, a large-scale, multi-site, national, longitudinal quantitative study that has operationalized community-based research in all steps of the research process
View PublicationAssessing the efficacy and safety of ledipasvir/sofosbuvir plus ribavirin for 24 weeks in 9 HIV/HCV–coinfected patients who relapsed after receiving 12 weeks of treatment with ledipasvir/sofosbuvir
View Publication